Search results for PX-TA1385

Showing 1 – 10 of1products
Inebilizumab Biosimilar – Anti-CD19 mAb – Research Grade Brand Logo
ID: BAB555180496

Inebilizumab Biosimilar – Anti-CD19 mAb – Research Grade, ProteoGenix, PX-TA1385

Description of Inebilizumab Biosimilar - Anti-CD19 mAb - Research Grade General information on Anti-CD19[Homo sapiens] (Inebilizumab) Monoclonal Antibody Inebilizumab is a humanized afucosylated monoclonal IgG1 antibody that targets the broadly expressed B-cell surface antigen CD19. Inebilizumab is cytolytic, which may be usefull to treat neuromyelitis optica spectrum disorder (NMOSD)through B-cell depletion.

Host

Reactivity

Applications

Conjugation

Request a product

Please provide the required information below so that we can quickly source your products.